EUPHRASIA AUGENTROPFEN

EUPHRASIA EYE DROPS

Important notes (Mandatory information)

Euphrasia Eye Drops.

Areas of application

According to anthroposophic understanding of human beings and nature. These include: structuring of the fluid organism in the eye area, e.g. catarrhal conjunctivitis.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


PACKAGE LEAFLET: INFORMATION FOR THE USER

Euphrasia Eye Drops

Composition

0.5 ml contain: Euphrasia ferm 33c Dil. D2 0.05 g, Rosae aetheroleum Dil. D7 0.05 g (HAB, Vs. 5a; Sol. D1 with Ethanol 94% (m/m)). Other ingredients: Sodium chloride, sodium bicarbonate, water for injections.

Areas of application

According to anthroposophic understanding of human beings and nature. These include: structuring of the fluid organism in the eye area, e.g. catarrhal conjunctivitis.

Contraindications

None known.

Dosage and method of administration

Unless otherwise prescribed, adults and children of all age groups should instill 1 drop into the conjunctival sac 1 to 2 times daily (see application instructions/dropping instructions).

Duration of use

Treatment of an acute illness should be completed after 2 weeks. If no improvement occurs within 2 days, a doctor should be consulted. The duration of treatment for chronic diseases requires consultation with a doctor.

Side effects

Eye irritations such as burning, redness, itching, swelling or increased tear flow may occur.

Note

Preservative-free, therefore also suitable for contact lens wearers. For dropping instructions, see General Explanations.

Content

30 x 0.5 ml

Pharmaceutical entrepreneur and manufacturer

WALA Heilmittel GmbH
Dorfstraße 1
73087 Bad Boll/Eckwälden

This package leaflet was last revised in January 2018.

Source: Information from the Wala catalogue
Status: 04/2019
Areas of application: According to anthroposophic understanding of human beings and nature. These include: structuring of the fluid organism in the eye area, e.g. catarrhal conjunctivitis.